Lontos K, Tsagianni A, Agha M, Raptis A, et al. A nomogram using cytogenetics, TP53, and NPM1 mutational status can predict responses to induction chemotherapy in AML. Leuk Lymphoma 2022;63:3257-3260.
PMID: 36075047